ArticlePDF Available

Planning, implementing and evaluating the effectiveness of health incentives: key considerations

Authors:

Abstract

Incentives are controversial, but increasingly widespread. Their basic rationales are not always clear, nor is the complexity of design options fully appreciated. Four common goals are outlined, and ten key dimensions of incentive programmes are described. Possible goal conflicts should be addressed through transparent communication and through monitoring the extent to which goals are in fact accomplished. Particular emphasis should be given to identifying the distribution of benefit among users. Regulators should specify broad categories in which data should be reported to help identify and promote appropriate programmes, and prevent or phase out inappropriate ones.
Euroh ealth O BSERV ER
Eurohealth incorporating Euro Obser ver Vol.20 | No.2 | 2014
10





Summary: Incentives are controversial, but increasingly widespread.
Their basic rationales are not always clear, nor is the complexity
of design options fully appreciated. Four common goals are outlined,
and ten key dimensions of incentive programmes are described.
Possible goal conflicts should be addressed through transparent
communication and through monitoring the extent to which goals
are in fact accomplished. Particular emphasis should be given to
identifying the distribution of benefit among users. Regulators should
specify broad categories in which data should be reported to help
identify and promote appropriate programmes, and prevent or phase
out inappropriate ones.


Haral d Schmid t is an Assistant
Profes sor, Departmen t of
Medical Ethics and Health
Policy and Research Associate,
Center for Health Incentives and
Behavioural Economics, Perelman
School of Medicine, Universit y
of Pennsylvania, USA. Email:
schmidth@mail.med.upenn.edu
Introduction




















Four rationales










Euroh ealth O BSERV ER
Eurohealth incorporating Euro Obser ver Vol.20 | No.2 | 2014
11



















 









 1 











  2


































 3 






























 4 











 5
























 








 


Euroh ealth O BSERV ER
Eurohealth incorporating Euro Obser ver Vol.20 | No.2 | 2014
12
Goals and goal conflicts




















  6 




 7 







 
The complex anatomy of incentive
programmes
































































































































Euroh ealth O BSERV ER
Eurohealth incorporating Euro Obser ver Vol.20 | No.2 | 2014
13













































  








 





























 





















Conclusion























8 














 9












References
1 Loewenstein G, Brennan T, Volpp KG. Asymmetric
paternalism to improve health behaviours. JAMA
2007;298(20):2415 7.
Euroh ealth O BSERV ER
Eurohealth incorporating Euro Obser ver Vol.20 | No.2 | 2014
14
2 Wolff J. Paying people to ac t in their own
interests: incentives ver sus rationalisation in
public health. Public He alth Ethics, In press.
3 Van Baal PH, Polder JJ, de Wit GA, et al. Lifetime
medical costs of obesity: prevention no cure for
increasing health expenditure. PLoS medi cine
2008;5(2):e29.
4 Cooper AL, Trivedi AN. Fitness member ships and
favorable selection in Medicare Advantage plans.
New England Journal of Medicine 2012;366(2):150 7.
5 Asch DA, Muller RW, Volpp KG. Conflicts and
compromises in not hiring smokers. N ew England
Journal of Medicine 2013;368 (15):1371 3.
6 Bundesministerium für Gesundheit. [Federal
Ministry of Health] Präventionsstrategie des Bund es,
2012 [Federal Prevention Str ategy]. Available at:
http://www.bmg.bund.de
7 Incentives for Nondiscriminatory Wellness
Programs in Group Health Plans, 78 Fed. Reg. 33,158
(3 June 2013).
8 Schmidt H. Bonuses as incentives and rewards
for health responsibility: a good thing? Journal of
Medicine and Philosophy 33.3 (200 8): 198 220.
9 Okun S, McGraw D, Stang P, et al. Making the
case for continuou s learning from routinely collected
data. Discussion Paper. Washington, DC: Institute of
Medicine, 2013.




Summary: Since the late 2000s, policy makers have made increasing
use of health incentives (‘nudges’). At the same time, criticism of
nudging has been mounting as well. In this article we argue that a
perspective drawing upon solidarity can help to create incentives that
are sensitive to social inequalities and that avoid increasing stigma.
This requires that policy makers give careful thought to the definition
of target groups for ‘nudging’. Moreover, health incentives should
also always focus on what people have in common, and not what
sets them apart.

Barba ra Prainsac k is Professor
of Sociology, Depar tment of Social
Science, Heal th & Medicine, King’s
College London, UK.
Alena B uyx is Professor of
Biomedical Ethics, Institute of
Experiment al Medicine, Chr istian-
Albrechts-University Kiel, Germany.
Email: Barbara.prainsack@kcl.ac.uk
Introduction







 1 


2 





Table 1















Table 1













... 56 Such incentives are less likely to coerce patients. Furthermore, lack of a certain reward may help avoid ''crowding-out'' intrinsic motivation, 56 which is concerning for several reasons 57 and has been observed empirically in some cases, 58 although not universally. 59,60 Incentive Frequency Incentive frequency may impact patients' susceptibility to present-biased preferences. ...
Article
Full-text available
Promising mHealth approaches for TB treatment adherence include: Video observation Patient- or device-facilitated indirect monitoring Direct monitoring through embedded sensors or metabolite testing To mitigate ethical concerns, our framework considers accuracy of monitoring technologies, stigmatization and intrusiveness of the technologies, use of incentives, and the balance of individual and public good.
... Ibid. Arneson ( 1997) Dworkin ( 2000) Roemer ( 1995) Roemer ( 1994) Callahan ( 1998) Engelhardt ( 1981) Wikler ( 1978) Wikler ( 2004) Buyx ( 2008) Wilkinson and Marmot ( 2003) Roemer ( 1995) Cappelen and Norheim ( 2005) Le Grand ( 1991) Feiring ( 2008) Callahan ( 2013) Rawls ( 1989) Daniels ( 2007) Daniels and Sabin ( 1999) Schmidt ( 2008) Scanlon ( 1998 The following section draws, in part directly, on a shorter version published as Schmidt ( 2014 ...
Chapter
Full-text available
Personal responsibility matters for both rationing and resource allocation. If people were healthier, there would be less competition for absolutely scarce resources such as organs or limited ICU beds. If fewer people were overweight, obese, or smokers, dilemmas arising from relative scarcity could be attenuated, as there would be reduced need for providing (and funding) interventions for conditions such as diabetes, heart disease, stroke, some cancers, or hip or knee-replacements. Yet, how to implement reasonable personal responsibility policies is far from straightforward. In the best case, the stars are aligned and programs empower people’s health literacy and agency, reduce overall healthcare spending, alleviate rationing and resource allocation dilemmas, and lead to healthier and more productive workforces. But the devil is often in the detail: a focus on controlling or reducing cost can also lead to an inequitable distribution of benefits from incentive programs, and penalize people for health risk factors that are beyond their control. This article reviews the different motivations that can underlie and drive personal responsibility policies; sets out a proposal for how to decide on the reasonableness of personal responsibility policies given the constraints of the realpolitik of health policy and the normative issues that are at stake; and provides an overview of central ethical issues raised by incentive programs, the dominant policy tool to promote personal responsibility.
Article
Maternal health is considered a key global priority by the World Health Organization, and several strategies are used to promote it. Especially in lower- and lower-middle-income countries, one widely used strategy employs financial incentives to motivate pregnant women to access available healthcare. While such interventions have been extensively empirically evaluated, their normative aspects appear to have received less attention. To address this gap, we systematically searched and reviewed normative and qualitative literature to map and analyze the ethical considerations of using financial incentives to promote maternal health. Twenty-three articles (four normative and 19 qualitative) were included in the review. We grouped ethical considerations under six categories, namely the program structure, promoting institutional births, of the ethical significance of cash, justifying conditionalities for maternal health, effects on individuals’ decision-making and the experiences of vulnerable groups. While incentives could be used for beneficent goals, we show how they may emphasize global rather than local solutions, impose unfamiliar sociocultural values, unfairly expect behavior change and disempower individuals and groups. We argue that future maternal health policy, especially those targeting vulnerable groups and minorities, would benefit from taking these normative considerations into account.
Article
Full-text available
Tobacco use is responsible for approximately 440,000 deaths in the United States each year - about one death out of every five. This number is more than the annual number of deaths caused by HIV infection, illegal drug use, alcohol use, motor vehicle injuries, suicides, and murders combined(1) and more than the number of American servicemen who died during World War II. A small but increasing number of employers - including health care systems such as the Cleveland Clinic, Geisinger, Baylor, and the University of Pennsylvania Health System - have established policies of no longer hiring tobacco users. These employers . . .
Article
Full-text available
Bonuses, as incentives or rewards for health-related behavior, feature prominently in German social health insurance. Their goal is centered around promoting personal responsibility, but reducing overall health-care expenditure and enabling competition between sickness funds also play a role. The central position of personal responsibility in German health-care policy is described, and a framework is offered for an analysis of the ethical issues raised by policies seeking to promote responsibility. The framework entails seven tests relating to: solidarity; equality and equity; intrusiveness; attributability and opportunity of choice; evidence, rationale, and feasibility; affected third parties; and coherence. It is contended that a focus on tests, in particular from within contractualism, is the most appropriate way of addressing the question of health responsibility in pluralistic societies. However, taken by themselves, the tests also allow an identification of the key ethical issues by particular policies, which are illustrated by applying the framework to particular bonus polices.
Article
Because Medicare Advantage plans must pay for covered services, they may design insurance benefits to appeal to healthier beneficiaries. We identified 11 Medicare Advantage plans that offered new fitness-membership benefits in 2004 or 2005 and matched these plans to 11 Medicare Advantage control plans that did not offer coverage for fitness memberships. Using a difference-in-differences approach, we compared the self-reported health status of persons who enrolled after the fitness benefit was added to the plan with the self-reported health status of persons entering the same plan before the fitness benefit was offered. The proportion of enrollees reporting excellent or very good health was 6.1 percentage points higher (95% confidence interval [CI], 2.6 to 9.7) among the 755 new enrollees in plans that added fitness benefits than among the 4097 earlier enrollees. The proportion of new enrollees reporting activity limitation was 10.4 percentage points lower (95% CI, 6.6 to 14.3) and the proportion reporting difficulty walking was 8.1 percentage points lower (95% CI, 4.4 to 11.7), as compared with earlier enrollees. Within control plans, the differences between the 1154 new enrollees and the 3910 earlier enrollees were 1.5 percentage points or less for each measure. The adjusted differences between the fitness-benefit plans and the control plans were 4.7 percentage points higher for general health (95% CI, 0.2 to 9.2), 9.2 percentage points lower for activity limitation (95% CI, 5.1 to 13.3), and 7.4 percentage points lower for difficulty walking (95% CI, 4.5 to 10.4). These differences persisted at 2 years for activity limitation and difficulty walking. Medicare Advantage plans offering coverage for fitness memberships may attract and retain a healthier subgroup of the Medicare population. (Funded by the National Institute on Aging.).
Article
Individual behavior plays a central role in the disease burden faced by society. Many major health problems in the United States and other developed nations, such as lung cancer, hypertension, and diabetes, are exacerbated by unhealthy behaviors. Modifiable behaviors such as tobacco use, overeating, and alcohol abuse account for nearly one-third of all deaths in the United States.1,2 Moreover, realizing the potential benefit of some of the most promising advances in medicine, such as medications to control blood pressure, lower cholesterol levels, and prevent stroke, has been stymied by poor adherence rates among patients.3 For example, by 1 year after having a myocardial infarction, nearly half of patients prescribed cholesterol-lowering medications have stopped taking them.4 Reducing morbidity and mortality may depend as much on motivating changes in behavior as on developing new treatments.5